Pretransplant CD4 Count Influences Immune Reconstitution and Risk of Infectious Complications in Human Immunodeficiency Virus-Infected Kidney Allograft Recipients
- Resource Type
- Authors
- Michele I. Morris; Warren Kupin; L. Chen; Gaetano Ciancio; Michael J. Goldstein; David M. Roth; Jacques Simkins; Giselle Guerra; George W. Burke; Rossana Rosa; Jose F. Camargo; Jose F. Suarez; Lilian M. Abbo; Adela Mattiazzi; Philip Ruiz; Marco Lorio
- Source
- American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons. 16(8)
- Subject
- CD4-Positive T-Lymphocytes
Graft Rejection
Male
HIV Infections
030230 surgery
Kidney Function Tests
Gastroenterology
0302 clinical medicine
Postoperative Complications
Risk Factors
Immunology and Allergy
Pharmacology (medical)
030212 general & internal medicine
Kidney transplantation
Kidney
biology
Graft Survival
Middle Aged
Allografts
Prognosis
medicine.anatomical_structure
Female
Glomerular Filtration Rate
Adult
medicine.medical_specialty
Globulin
Renal function
Article
03 medical and health sciences
Immune system
Internal medicine
medicine
Humans
Aged
Antilymphocyte Serum
Retrospective Studies
Transplantation
AIDS-Related Opportunistic Infections
business.industry
Retrospective cohort study
medicine.disease
Kidney Transplantation
Confidence interval
CD4 Lymphocyte Count
Relative risk
Immunology
biology.protein
HIV-1
business
Follow-Up Studies
- Language
- ISSN
- 1600-6143
In current practice, human immunodeficiency virus-infected (HIV(+) ) candidates with CD4 >200 cells/mm(3) are eligible for kidney transplantation; however, the optimal pretransplant CD4 count above this threshold remains to be defined. We evaluated clinical outcomes in patients with baseline CD4 >350 and